Technical Data for Procurement & R&D

Precision Fermentation Ingredient Platforms

Transparent documentation for two focused B2B platforms: fermented Salidroside and HMO Series. Request technical files, samples, and specification support for procurement review.

Fermentation

HMOs (Human Milk Oligosaccharides)

Our precision yeast fermentation platform is designed to avoid the endotoxin-management burden associated with legacy E. coli processes. Purity targets can exceed 98%, supported by batch documentation.

We provide scalable commercial volumes for 2'-FL, 3-FL, LNT, and LNnT with complete transparency.

Variants: 2'-FL, LNT, LNnT, 3-FL

Variants: 2'-FLLNTLNnT3-FL

Technical Specifications

Purity (HPLC)

≥ 98%

pH (1% solution)

6.7 (Neutral)

Production Host

Food-grade Yeast

Safety

Inherently Endotoxin-Free

Technical Specifications

Purity Range

60% to ≥98%

Source

Precision Fermentation

Documentation

Project-specific support

Contamination Pathway

Reduced soil-related exposure

Biosynthesis

Fermented Salidroside

Produced via fermentation rather than wild plant extraction to reduce supply variability and soil-related contamination pathways. Documentation support is available on request.

Designed for scalable commercial output, with project-dependent purity that can reach up to ≥98%.

Quality Advantages

  • Fermentation-derived
  • documentation support available
  • scalable supply planning
  • purity up to ≥98% (project-dependent).
Products | Morika Bio